Proteomics

Dataset Information

0

Proteome dynamics during cisplatin exposure in sensitive and resistant human lung cancer cells


ABSTRACT: Lung cancer is the leading cause of cancer-related deaths and its treatment is based in chemotherapy using platinum containing compounds, mainly cisplatin (CDDP). Many patients show resistance to CDDP leading to treatment failure. To understand the mechanisms involved in CDDP resistance in lung cancer, we used CDDP-sensitive (A549) and –resistant (A549/CDDP) cells to identify newly synthesized proteins in response to CDDP treatment using BONCAT technique. In addition the steady-state proteome of A549 and A549/CDDP cells was also evaluated. It was identified 70 and 69 proteins upregulated by CDDP in A549 and A549/CDDP cells, respectively. The set of proteins upregulated by CDDP in both cells are associated to GO terms related to proteostasis, telomere maintenance cell, RNA processing, cytoskeleton and response to oxidative stress. Interestingly, the profile of biological processes enriched in A549 cells after CDDP treatment is very similar to those identified in the steady-state proteome of A549/CDDP cells, suggesting their positive selection in CDDP-resistant cells development. Therefore, this study of proteomic response to CDDP is relevant to the identification of potential protein targets to development of therapeutic strategies to block drug resistance pathways.

INSTRUMENT(S): Xevo G2-XS Tof

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Lung Cancer

SUBMITTER: Cristine Dutra  

LAB HEAD: Karina Mariante Monteiro

PROVIDER: PXD021779 | Pride | 2023-03-10

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

Proteomic Analysis of the Non-genetic Response to Cisplatin in Lung Cancer Cells.

DE Souza Dutra Cristine C   Martello Carolina Lumertz CL   Cadore Nathan Araujo NA   Ferreira Henrique Bunselmeyer HB   Zaha Arnaldo A   Monteiro Karina Mariante KM  

Cancer diagnosis & prognosis 20210703 3


<h4>Background</h4>Drug resistance is the main cause of therapy failure in advanced lung cancer. Although non-genetic mechanisms play important roles in tumor chemoresistance, drug-induced epigenetic reprogramming is still poorly understood.<h4>Materials and methods</h4>The A549 cell line was used to generate cells with non-genetic resistance to cisplatin (CDDP), namely A549/CDDP cells. Bioorthogonal non-canonical amino acid tagging (BONCAT) and mass spectrometry were used to identify proteins m  ...[more]

Similar Datasets

2015-04-10 | E-GEOD-67727 | biostudies-arrayexpress
2013-01-15 | E-GEOD-43493 | biostudies-arrayexpress
2013-01-15 | E-GEOD-43249 | biostudies-arrayexpress
2021-05-31 | GSE157692 | GEO
2019-08-12 | PXD013265 | Pride
2015-04-10 | GSE67727 | GEO
2021-09-09 | PXD017645 | Pride
2012-02-24 | E-MEXP-3123 | biostudies-arrayexpress
2012-06-13 | E-GEOD-32176 | biostudies-arrayexpress
2010-10-29 | E-GEOD-24984 | biostudies-arrayexpress